Editor's Pick
Jeffrey A. Singer On May 13, the Food and Drug Administration announced plans to pull fluoride supplements, such as tablets and drops, off the...
Connect with us
Hi, what are you looking for?
Gain That Flavour
- Investing
Friday Feature: Chesapeake Bay Academy
US Withdrawal from the World Trade Organization Would Be an Epic Mistake
House Tax Bill Doesn’t Kill Green New Deal Subsidies Fast Enough
Wagyu Farmer in Congress Wants Tariffs on Australian Wagyu
Young Americans Like Socialism Too Much—That’s a Problem Libertarians Must Fix
- Stock
Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!
S&P 500 Now in Weakest Seasonal Period… Or Is It?
The Stock Market’s Comeback: Key Takeaways for Investors
SPY and QQQ Recapture their 200-day SMAs – Tips for Reducing Whipsaws and Improving Performance
Applying Dow Theory to Today’s Market: Are We in a Reversal or a New Trend?
- Politics
Republicans ready late-night session on Trump’s ‘big, beautiful bill’ after GOP mutiny
Dems’ hearing meltdowns a play to the base, analysts say, as Trump noms keep pushing back in viral moments
Trump’s idea to make Americans have babies again gets mixed reviews from experts
DAVID MARCUS: Old Man Biden’s autopen pardons should be null and void
WH study warns 9 million Americans could lose health insurance in ‘major’ recession if Trump budget bill fails
- Editor’s Pick
Emerging Stocks to Watch – Breakouts, Momentum & Upgrades!
S&P 500 Now in Weakest Seasonal Period… Or Is It?
The Stock Market’s Comeback: Key Takeaways for Investors
SPY and QQQ Recapture their 200-day SMAs – Tips for Reducing Whipsaws and Improving Performance
Applying Dow Theory to Today’s Market: Are We in a Reversal or a New Trend?
Editor's Pick
Looking for breakout stocks and top market leaders? Follow along Mary Ellen shares stock breakouts, analyst upgrades, and sector leadership trends to help you...
Editor's Pick
We’ve all heard the classic market maxim, “Sell in May and go away.” For many investors, that’s the introduction to market seasonality that suggests...
Editor's Pick
If you didn’t check in on the stock market the last couple of weeks, you might be surprised to see how strong they were...
Editor's Pick
For months, investors have been on edge over U.S.-China tariff tensions, bracing for everything from fears of empty shelves to rising prices. But after...
Editor's Pick
Alex Nowrasteh The first group of Afrikaners from South Africa to arrive for resettlement listen to remarks from US Deputy Secretary of State Christopher...
Editor's Pick
Neal McCluskey A $5 billion scholarship tax credit is a part of the budget reconciliation bill just introduced in Congress. As a member of...
Editor's Pick
We’ve been cautious about the uptrend phase off the April low for a number of reasons, including the lack of breadth support. While short-term...
Editor's Pick
Bullish signal alert! Over 50% of S&P 500 stocks are now above their 200-day moving average. In this video, Dave explains this key market...
Editor's Pick
Dominik Lett Medicaid, a joint state and federal medical care program, already costs more than national defense. And despite $1.1 trillion in improper payments...
Editor's Pick
Chris Edwards On May 11, 60 Minutes examined the huge fraud problem in federal spending programs. The piece stressed the growing losses from large-scale...
Editor's Pick
Let’s be honest. Did anyone think a little more than a month ago that the S&P 500 was primed for a 1000-point rebound? I...
Editor's Pick
Colin Grabow One hopeful theory behind the Trump administration’s “Liberation Day” tariff increases was that they were a negotiating tool to ultimately produce a...